Development of a Duplex Real-Time PCR Assay for the Differentiation of Blastomyces dermatitidis and Blastomyces gilchristii and a Retrospective Analysis of Culture and Primary Specimens from Blastomycosis Cases from New York (2005 to 2019)

Blastomycosis due to Blastomyces dermatitidis and Blastomyces gilchristii is a significant cause of respiratory mycoses in North America with occasional reported outbreaks. We developed a highly sensitive, specific, and reproducible TaqMan duplex real-time PCR assay for the differentiation of B. dermatitidis and B. gilchristii. ABSTRACT Blastomycosis due to Blastomyces dermatitidis and Blastomyces gilchristii is a significant cause of respiratory mycoses in North America with occasional reported outbreaks. We developed a highly sensitive, specific, and reproducible TaqMan duplex real-time PCR assay for the differentiation of B. dermatitidis and B. gilchristii. The new assay permitted retrospective analysis of Blastomyces cultures (2005 to 2019) and primary clinical specimens from blastomycosis cases (2013 to 2019) from New York patients. We identified B. dermatitidis as the predominant pathogen in 38 cases of blastomycosis, while B. gilchristii was a minor pathogen involved in five cases; these findings expand understanding of blastomycosis in New York. The duplex real-time PCR assay could be implemented in reference and public health laboratories to further understand the ecology and epidemiology of blastomycosis due to B. dermatitidis and B. gilchristii.

[1]  David M. Jones,et al.  Blastomycosis in the Capital District of New York State: A Newly Identified Emerging Endemic Area. , 2020, American Journal of Medicine.

[2]  N. Bethuel,et al.  Pulmonary blastomycosis in rural Upstate New York: A case series and review of literature , 2020, Annals of thoracic medicine.

[3]  V. Chaturvedi,et al.  Onygenalean Fungi as Major Human and Animal Pathogens , 2020, Mycopathologia.

[4]  Christina A. Cuomo,et al.  Human Blastomycosis in South Africa Caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967 to 2014 , 2020, Journal of Clinical Microbiology.

[5]  B. Jackson,et al.  Notes from the Field: Blastomycosis Cases Occurring Outside of Regions with Known Endemicity — New York, 2007–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[6]  A. Stchigel,et al.  Phylogeny, ecology and taxonomy of systemic pathogens and their relatives in Ajellomycetaceae (Onygenales): Blastomyces, Emergomyces, Emmonsia, Emmonsiellopsis , 2018, Fungal Diversity.

[7]  Christina A. Cuomo,et al.  Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales) , 2017, Mycoses.

[8]  S. Richardson,et al.  Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins , 2016, PloS one.

[9]  J. Kus,et al.  Blastomyces gilchristii as Cause of Fatal Acute Respiratory Distress Syndrome , 2016, Emerging infectious diseases.

[10]  Q. Kaewpoowat,et al.  Pulmonary blastomycosis: a new endemic area in New York state , 2013, Mycoses.

[11]  D. Low,et al.  Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis , 2013, PloS one.

[12]  J. Meece,et al.  Variation in clinical phenotype of human infection among genetic groups of Blastomyces dermatitidis. , 2013, The Journal of infectious diseases.

[13]  D. Baumgardner,et al.  Real-Time PCR Assay for Identification of Blastomyces dermatitidis in Culture and in Tissue , 2012, Journal of Clinical Microbiology.

[14]  S. Arnold,et al.  Blastomycosis , 2011, Red Book Atlas of Pediatric Infectious Diseases.

[15]  M. Fisher,et al.  Population Genetic Structure of Clinical and Environmental Isolates of Blastomyces dermatitidis, Based on 27 Polymorphic Microsatellite Markers , 2011, Applied and Environmental Microbiology.

[16]  G. Woods,et al.  Clinical and Laboratory Update on Blastomycosis , 2010, Clinical Microbiology Reviews.

[17]  W. Schwan,et al.  PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples. , 2006, Medical mycology.

[18]  T. Herrmann,et al.  Nested PCR Assays for Detection of Blastomyces dermatitidis DNA in Paraffin-Embedded Canine Tissue , 2003, Journal of Clinical Microbiology.

[19]  J. Myers,et al.  Pulmonary blastomycosis with acute respiratory failure as predominant clinical feature. , 1997, Southern medical journal (Birmingham, Ala. Print).

[20]  B. Aizenstein,et al.  African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1 , 1997, Infection and immunity.

[21]  S. Barr,et al.  Blastomycosis in six dogs in New York state. , 1997, Journal of the American Veterinary Medical Association.

[22]  B. Klein,et al.  Genomic Cloning, Characterization, and Functional Analysis of the Major Surface Adhesin WI-1 on Blastomyces dermatitidis Yeasts (*) , 1995, The Journal of Biological Chemistry.

[23]  J. P. Davis,et al.  Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. , 1987, The American review of respiratory disease.

[24]  B. Varkey,et al.  Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. , 1987, The Journal of infectious diseases.

[25]  T. Gilchrist,et al.  A CASE OF PSEUDO-LUPUS VULGARIS CAUSED BY A BLASTOMYCES , 1898, The Journal of experimental medicine.

[26]  Dennis J Baumgardner,et al.  Genetic diversity in Blastomyces dermatitidis: implications for PCR detection in clinical and environmental samples. , 2010, Medical mycology.

[27]  M. Wüthrich,et al.  BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms. , 2002, Journal of Immunology.